Full Text
REGD. No. D. L.-33004/99
The Gazette of India
CG-DL-E-30012026-269671
EXTRAORDINARY
PART II-Section 3-Sub-section (ii)
PUBLISHED BY AUTHORITY
No. 421]
NEW DELHI, FRIDAY, JANUARY 30, 2026/MAGHA 10, 1947
643 GI/2026
MINISTRY OF CHEMICALS AND FERTILIZERS
(Department of Pharmaceuticals)
(NATIONAL PHARMACEUTICAL PRICING AUTHORITY)
ORDER
New Delhi, the 30th January, 2026
S.O. 449(E).—In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order,
2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the
Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority
(hereinafter referred as NPPA) hereby fixes, the price as specified in column (6) of the table herein below as the retail price,
exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column
(2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the
corresponding entries in columns (3), (4) and (5) thereof;
TABLE
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| Sl. | Name of the | Strength | Unit | Manufacturer & | Retail |
| No. | Formulation / | | | Marketing Company | Price (Rs.) |
| | Brand Name | | | | |
+=====+==================================+============================================================+===========+==================================+===============+
| (1) | (2) | (3) | (4) | (5) | (6) |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 1 | Atorvastatin & | Each Film Coated Tablet contains: | 1 Tablet | M/s Pure & Cure | 20.00 |
| | Ezetimibe Tablets | Atorvastatin Calcium IP eq. to Atorvastatin 10 mg | | Healthcare Pvt. Ltd./ | |
| | | Ezetimibe IP 10 mg | | M/s Mankind Pharma Ltd. | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 2 | Atorvastatin & | Each Film Coated Tablet contains: | 1 Tablet | M/s Pure & Cure | 25.00 |
| | Ezetimibe Tablets | Atorvastatin Calcium IP eq. to Atorvastatin 20 mg | | Healthcare Pvt. Ltd./ | |
| | | Ezetimibe IP 10 mg | | M/s Mankind Pharma Ltd. | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 3 | Atorvastatin & | Each Film Coated Tablet Contains: | 1 Tablet | M/s Pure & Cure | 31.90 |
| | Ezetimibe Tablets | Atorvastatin Calcium IP Eq. to Atorvastatin 40 mg | | Healthcare Pvt. Ltd./ | |
| | | Ezetimibe IP 10 mg | | M/s Mankind Pharma Ltd. | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 4 | Atorvastatin & | Each Film Coated Tablet contains: | 1 Tablet | M/s Macleods | 20.98 |
| | Ezetimibe Tablets | Atorvastatin Calcium IP eq. to Atorvastatin 10 mg | | Pharmaceuticals Ltd. | |
| | | Ezetimibe IP 10 mg | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 5 | Atorvastatin & | Each Film Coated Tablet contains: | 1 Tablet | M/s Macleods | 30.10 |
| | Ezetimibe Tablets | Atorvastatin Calcium IP eq. to Atorvastatin 20 mg | | Pharmaceuticals Ltd. | |
| | | Ezetimibe IP 10 mg | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 6 | Atorvastatin & | Each Film Coated Tablet contains: | 1 Tablet | M/s Macleods | 31.90 |
| | Ezetimibe Tablets | Atorvastatin Calcium IP eq. to Atorvastatin 40 mg | | Pharmaceuticals Ltd. | |
| | | Ezetimibe IP 10 mg | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 7 | Calcium Citrate, | Each Film Coated Tablet Contains: | 1 Tablet | M/s Troikaa | 14.37 |
| | Vitamin D3, | Calcium Citrate USP 1000 mg | | Pharmaceuticals Ltd. | |
| | Methylcobalamin, | Vitamin D3 IP 200 IU | | | |
| | Pyridoxine HCL | Methylcobalamin IP 500 mcg | | | |
| | and Folic Acid Tablets | Pyridoxine Hydrochloride IP 10 mg | | | |
| | | Folic Acid IP 5 mg | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 8 | Cefuroxime Axetil | Each film coated tablet contains: | 1 Tablet | M/s Theon | 38.14 |
| | and Potassium | Cefuroxime Axetil IP eq. to Anhydrous Cefuroxime 250 mg | | Pharmaceuticals Ltd./ | |
| | Clavulanate Tablets | Potassium Clavulanate Diluted IP eq. to Clavulanic Acid | | M/s Emcure Lifesciences | |
| | | 125 mg | | Pvt. Ltd. | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 9 | Cefuroxime Axetil | Each film coated tablet contains: | 1 Tablet | M/s Theon | 63.94 |
| | and Potassium | Cefuroxime Axetil IP eq. to Anhydrous Cefuroxime 500 mg | | Pharmaceuticals Ltd./ | |
| | Clavulanate Tablets | Potassium Clavulanate Diluted IP eq. to Clavulanic Acid | | M/s Emcure Lifesciences | |
| | | 125 mg | | Pvt. Ltd. | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 10 | Chlorpheniramine | Each 5 ml contains: | 1 ml | M/s East African (I) | 0.98 |
| | Maleate, | Chlorpheniramine Maleate IP 2 mg | | Overseas/ | |
| | Phenylephrine | Phenylephrine Hydrochloride IP 5 mg | | M/s SRK Puremed LLP | |
| | Hydrochloride & | Dextromethorphan Hydrobromide IP 10 mg | | | |
| | Dextromethorphan Syrup | | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 11 | Ciprofloxacin and | Each film coated tablet contains: | 1 Tablet | M/s East African (I) | 8.00 |
| | Tinidazole Tablets | Ciprofloxacin Hydrochloride IP Eq. to Ciprofloxacin 500mg | | Overseas/ | |
| | | Tinidazole IP 600mg | | M/s SRK Puremed LLP | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 12 | Clindamycin and | Composition: | 1 gm | M/s Om Sai Pharma Pack/ | 7.78 |
| | Tretinoin Gel | Clindamycin Phosphate IP Equivalent to Clindamycin 1.0% | | M/s Cipla Ltd. | |
| | | w/w | | | |
| | | Tretinoin USP 0.025% w/w (As microspheres) | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 13 | Combikit of | Composition: | 1 kit | M/s Malik Lifesciences | 167.21 |
| | Clarithromycin | Each Strip Contains: | | Pvt. Ltd./ | |
| | Tablets, | A. Clarithromycin Tablets IP 2 Tablets | | M/s Primus Remedies Pvt. | |
| | Esomeprazole Tablets and | Each Film Coated Tablet Contains: | | Ltd. | |
| | Amoxicillin Tablets | Clarithromycin IP 500 mg | | | |
| | | B. Esomeprazole Tablets IP 2 | | | |
| | | Tablets | | | |
| | | Each Enteric Coated Tablet Contains: | | | |
| | | Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole | | | |
| | | 40 mg | | | |
| | | C. Amoxicillin Tablets USP 2 Tablets | | | |
| | | Each Film Coated Tablet Contains: | | | |
| | | Amoxycillin Trihydrate IP eq. to Amoxycillin 1000 mg | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 14 | Dapagliflozin and | Each film coated tablet contains: | 1 Tablet | M/s Exemed | 18.56 |
| | Telmisartan Tablets | Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg | | Pharmaceuticals/ | |
| | | Telmisartan IP 40 mg | | M/s Eris Lifesciences Ltd. | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 15 | Diclofenac | Each ml contains: | 1 ml | M/s Nitin Lifesciences Ltd./ | 32.99 |
| | Injection 1ml Glass Ampoule | Diclofenac Sodium IP 75 mg | | M/s Aristo Pharmaceuticals Pvt. | |
| | | | | Ltd. | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 16 | Diclofenac | Each enteric coated tablet contains: | 1 Tablet | M/s East African (I) Overseas/ | 3.05 |
| | Potassium and | Diclofenac Potassium IP 50 mg | | M/s SRK Puremed LLP | |
| | Serrattiopeptidase Tablets | Serrattiopeptidase IP 10 mg (Eq.to 20,000 units of enzyme | | | |
| | | activity) | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 17 | Enteric Coated | Each hard gelatin capsule contains: | 1 Capsule | M/s Innova Captab Ltd./ | 20.13 |
| | Pantoprazole and | Pantoprazole Sodium Sesquihydrate IP Equivalent to | | M/s Emcure Pharmaceuticals Ltd. | |
| | Sustained Release | Pantoprazole 40 mg (As enteric coated pellets) | | | |
| | Levosulpiride Capsules | Levosulpiride 75 mg (As sustained release tablet) | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 18 | Gliclazide | Each uncoated bi-layered tablet contains: | 1 Tablet | M/s Mascot Health Series Pvt. | 7.92 |
| | modified-release | Gliclazide IP 30mg (in modified-release form) | | Ltd./ | |
| | and Metformin | Metformin Hydrochloride IP 500mg (in extended release | | M/s Primus Remedies Pvt. Ltd. | |
| | HCL extended release Tablets | form) | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 19 | Gliclazide | Each uncoated bi-layered tablet contains: | 1 Tablet | M/s Mascot Health Series Pvt. | 10.00 |
| | modified-release | Gliclazide IP 60mg (in modified-release form) | | Ltd./ | |
| | and Metformin | Metformin Hydrochloride IP 500mg (in extended release | | M/s Primus Remedies Pvt. Ltd. | |
| | HCL extended release Tablets | form) | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 20 | Mefenamic Acid | Each film coated tablet contains: | 1 Tablet | M/s East African (I) Overseas/ | 3.05 |
| | and Dicyclomine Tablets | Mefenamic Acid IP 250 mg | | M/s SRK Puremed LLP | |
| | | Dicyclomine Hydrochloride IP 10 mg | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 21 | Meropenem and | Each Combi Pack contains: | 1 vial | M/s Venus Remedies Ltd. | 1835.79 |
| | Sulbactam for Injection | A) Each Vial contains: | | | |
| | | Meropenem I.P Equivalent to Meropenem (Anhydrous) 1g | | | |
| | | Sodium (as Sodium Carbonate I.P) 90.2mg | | | |
| | | Sulbactam Sodium I.P Equivalent to Sulbactam 500 mg | | | |
| | | B) One ampoule of solvent contains: | | | |
| | | Sterile Water for Injections I.P 20 ml | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 22 | Myo-Inositol & | Each Film Coated Bilayered Tablet Contains: | 1 Tablet | M/s Akums Drugs & | 23.59 |
| | Metformin | Myo-Inositol IP 600 mg | | Pharmaceuticals Ltd./ | |
| | Hydrochloride (SR) Tablets | Metformin Hydrochloride IP 500 mg (As sustained release) | | M/s Sun Pharma Laboratories | |
| | | | | Limited | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 23 | Myo-Inositol & | Each Film Coated Bilayered Tablet Contains: | 1 Tablet | M/s Akums Drugs & | 23.59 |
| | Metformin | Myo-Inositol IP 600 mg | | Pharmaceuticals Ltd./ | |
| | Hydrochloride (SR) Tablets | Metformin Hydrochloride IP 500 mg (As sustained release) | | M/s Macleods Pharmaceuticals | |
| | | | | Ltd. | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 24 | Myo-Inositol & | Each Film Coated Bilayered Tablet Contains: | 1 Tablet | M/s Akums Drugs & | 23.59 |
| | Metformin | Myo-Inositol IP 600 mg | | Pharmaceuticals Ltd./ | |
| | Hydrochloride (SR) Tablets | Metformin Hydrochloride IP 500 mg (As sustained release) | | M/s Zydus Healthcare Ltd. | |
| | | | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 25 | Paracetamol, | Each Film Coated Tablet Contains: | 1 Tablet | M/s Pure & Cure | 4.64 |
| | Phenylephrine | Paracetamol IP 500mg | | Healthcare Pvt. Ltd./ | |
| | Hydrochloride, | Phenylephrine Hydrochloride IP 5mg | | M/s Abbott Healthcare Pvt. Ltd. | |
| | Caffeine and | Caffeine (Anhydrous) IP 30mg | | | |
| | Diphenhydramine Hydrochloride | Diphenhydramine Hydrochloride IP 25 mg | | | |
| | Tablets | | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 26 | Paracetamol, | Each uncoated tablet contains: | 1 Tablet | M/s Innova Captab Ltd./ | 4.64 |
| | Phenylephrine | Paracetamol IP 500 mg | | M/s Softdeal Pharmaceutical | |
| | Hydrochloride, | Phenylephrine HCl IP 5 mg | | Pvt. Ltd. | |
| | Caffeine and | Caffeine (Anhydrous) IP 30 mg | | | |
| | Diphenhydramine Hydrochloride | Diphenhydramine HCI IP 25 mg | | | |
| | Tablets | | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 27 | Telmisartan, | Each film coated tablet contains: | 1 Tablet | M/s Glenmark Pharmaceuticals | 16.40 |
| | Cilnidipine and | Telmisartan IP 40 mg | | Ltd. | |
| | Chlorthalidone Tablets | Cilnidipine IP 10 mg | | | |
| | | Chlorthalidone IP 12.5 mg | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 28 | Empagliflozin, | Each film coated bilayer tablet contains: | 1 Tablet | M/s Exemed Pharmaceuticals/ | 20.27 |
| | Linagliptin, | Empagliflozin 25 mg | | M/s. Abbott Healthcare Pvt. Ltd. | |
| | Metformin | Linagliptin 5 mg | | | |
| | Hydrochloride | Metformin Hydrochloride (As Extended Release) IP 1000 mg | | | |
| | Extended Release Tablets | | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 29 | Empagliflozin, | Each film coated bilayer tablet contains: | 1 Tablet | M/s Exemed Pharmaceuticals/ | 19.80 |
| | Sitagliptin, | Empagliflozin 10 mg | | M/s. Abbott Healthcare Pvt. Ltd. | |
| | Metformin | Metformin Hydrochloride (As Extended Release) IP 1000 mg | | | |
| | Hydrochloride | Sitagliptin Phosphate Monohydrate IP Equivalent to | | | |
| | Extended Release Tablets | Sitagliptin 100 mg | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 30 | Empagliflozin, | Each film coated bilayer tablet contains: | 1 Tablet | M/s Exemed Pharmaceuticals/ | 21.43 |
| | Sitagliptin, | Empagliflozin 25 mg | | M/s. Abbott Healthcare Pvt. Ltd. | |
| | Metformin | Sitagliptin Phosphate Monohydrate IP Equivalent to | | | |
| | Hydrochloride | Sitagliptin 100 mg | | | |
| | Extended Release Tablets | Metformin Hydrochloride (As Extended Release) IP 1000 mg | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 31 | Empagliflozin, | Each film coated tablet contains: | 1 Tablet | M/s Pure and Cure | 20.27 |
| | Linagliptin, | Empagliflozin 25 mg | | Healthcare Pvt. Ltd./ | |
| | Metformin | Linagliptin 5 mg | | M/s MSN Laboratories Pvt. Ltd. | |
| | Hydrochloride (ER) Tablets | Metformin Hydrochloride IP 1000 mg (as Extended Release) | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 32 | Cetirizine | Each ml Contains: | 1 ml | M/s Akums Drugs & | 14.42 |
| | Ophthalmic | Cetirizine Hydrochloride IP Eq. to Cetirizine 0.24% w/v | | Pharmaceuticals Ltd./ | |
| | Solution 0.24% w/v | Benzalkonium Chloride Solution IP 0.02 % v/v | | M/s Dr. Reddys Laboratories Ltd. | |
| | | (As preservative) | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 33 | Cetirizine | Each ml Contains: | 1 ml | M/s Akums Drugs & | 14.42 |
| | Ophthalmic | Cetirizine Hydrochloride IP Eq. to Cetirizine 0.24% w/v | | Pharmaceuticals Ltd./ | |
| | Solution 0.24% w/v | Benzalkonium Chloride Solution IP 0.02 % v/v | | M/s Mankind Pharma Ltd. | |
| | | (As preservative) | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 34 | Ready to use | Each ml contains: | 1 Bag | M/s Sun Pharmaceutical | 5977.68 |
| | Infusion bags | Gemcitabine Hydrochloride IP equivalent to Gemcitabine | | Industries Ltd./ | |
| | Gemcitabine | 10 mg | | M/s Sun Pharma Laboratories | |
| | Hydrochloride | Sodium Chloride IP 9 mg | | Ltd. | |
| | Injection 10mg/ml | | | | |
| | (1200mg/120ml) | | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 35 | Ready to use | Each ml contains: | 1 Bag | M/s Sun Pharmaceutical | 7183.04 |
| | Infusion bags | Gemcitabine Hydrochloride IP equivalent to Gemcitabine | | Industries Ltd./ | |
| | Gemcitabine | 10 mg | | M/s Sun Pharma Laboratories | |
| | Hydrochloride | Sodium Chloride IP 9 mg | | Ltd. | |
| | Injection 10mg/ml | | | | |
| | (1400mg/140ml) | | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
| 36 | Ready to use | Each ml contains: | 1 Bag | M/s Sun Pharmaceutical | 8079.63 |
| | Infusion bags | Gemcitabine Hydrochloride IP equivalent to Gemcitabine | | Industries Ltd./ | |
| | Gemcitabine | 10 mg | | M/s Sun Pharma Laboratories | |
| | Hydrochloride | Sodium Chloride IP 9 mg | | Ltd. | |
| | Injection 10mg/ml | | | | |
| | (1600mg/160ml) | | | | |
+-----+----------------------------------+------------------------------------------------------------+-----------+----------------------------------+---------------+
Notes:
(a) The manufacturer of above-mentioned formulations i.e., "new drug" under paragraph 2(1)(u) of the DPCO,
2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the
Government on the retail price mentioned in column (6) of the above said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in
accordance with the retail price specified in column (6) of the above table as per provisions contained in
paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form-V from date of Notification
as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller
and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price
list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business
in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned
above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under
DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt.
under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e.
the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing
companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification
and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit
the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the
Essential Commodities Act, 1955.
(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with
the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in
Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength
for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5)
thereof, if any, issued prior to this notification, stand(s) superseded.
[PN/274/142/2026/F/F. No. 8(142)/2026/D.P./NPPA-Div.-II]
BHIVA RAM YADAV, Assistant Director